These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 28731243

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A new era in the management of psoriasis? The biologics: facts and controversies.
    Ferrándiz C, Carrascosa JM, Boada A.
    Clin Dermatol; 2010; 28(1):81-7. PubMed ID: 20082956
    [Abstract] [Full Text] [Related]

  • 3. The role of biologics and other systemic agents in the treatment of pediatric psoriasis.
    Wright NA, Piggott CD, Eichenfield LF.
    Semin Cutan Med Surg; 2010 Mar; 29(1):20-7. PubMed ID: 20430304
    [No Abstract] [Full Text] [Related]

  • 4. Non-tuberculous mycobacterial infections in psoriasis patients treated with biologics.
    Choi YM, Adelzadeh L, Wu JJ.
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e99-e101. PubMed ID: 26388307
    [No Abstract] [Full Text] [Related]

  • 5. Why Biologic Therapies Sometimes Lose Efficacy.
    Strober BE.
    Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S78-80. PubMed ID: 27525443
    [Abstract] [Full Text] [Related]

  • 6. Combining biologics with methotrexate in psoriasis: a systematic review.
    van Bezooijen JS, Prens EP, Pradeepti MS, Atiqi R, Schreurs MWJ, Koch BCP, van Gelder T, van Doorn MBA.
    Br J Dermatol; 2015 Jun; 172(6):1676-1680. PubMed ID: 25470815
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proposal for long-term protocols after Psoriasis Area and Severity Index clear with initial biologic therapy: Happily ever after with or without biologics in psoriasis therapy.
    Sano S.
    J Dermatol; 2017 Oct; 44(10):e234-e235. PubMed ID: 28623843
    [No Abstract] [Full Text] [Related]

  • 9. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J, Kerdel F.
    Dermatol Ther; 2008 Oct; 21(2):131-41. PubMed ID: 18394087
    [Abstract] [Full Text] [Related]

  • 10. Practical experience of biologics for treatment of very severe psoriasis: a retrospective case cohort study of patients with a baseline Psoriasis Area and Severity Index greater than 20.
    Ponnambath N, Kalavala M, Anstey AV, Piguet V, Ingram JR.
    Clin Exp Dermatol; 2016 Jan; 41(1):95-6. PubMed ID: 25817265
    [No Abstract] [Full Text] [Related]

  • 11. Are biologics useful for nail psoriasis?
    Antúnez-Lay A, Cabrolier J, Andino-Navarrete R.
    Medwave; 2016 Jan 11; 16 Suppl 1():e6363. PubMed ID: 26817583
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
    van de Kerkhof PC, Mrowietz U, Segaert S, Kragballe K.
    Br J Dermatol; 2007 Apr 11; 156(4):771-2. PubMed ID: 17263798
    [No Abstract] [Full Text] [Related]

  • 13. New therapies under development for psoriasis treatment.
    García-Pérez ME, Stevanovic T, Poubelle PE.
    Curr Opin Pediatr; 2013 Aug 11; 25(4):480-7. PubMed ID: 23838833
    [Abstract] [Full Text] [Related]

  • 14. Practical Strategies for Optimizing Management of Psoriasis.
    Wu JJ, Armstrong AW, Gordon KB, Menter MA.
    Semin Cutan Med Surg; 2018 Feb 11; 37(2S):S52-S55. PubMed ID: 29614139
    [Abstract] [Full Text] [Related]

  • 15. The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics.
    Levine D, Strober BE.
    Semin Cutan Med Surg; 2010 Mar 11; 29(1):28-34. PubMed ID: 20430305
    [Abstract] [Full Text] [Related]

  • 16. Challenges in the treatment of psoriasis with biologics: vaccination, history of malignancy, human immunodeficiency virus (HIV) infection, and pediatric psoriasis.
    Plachouri KM, Georgiou S.
    Int J Dermatol; 2019 Sep 11; 58(9):1008-1013. PubMed ID: 30891751
    [Abstract] [Full Text] [Related]

  • 17. Experience and challenges for biologic use in the treatment of moderate-to-severe psoriasis in Africa and the Middle East region.
    Al Hammadi A, Al-Sheikh A, Ammoury A, Ghosn S, Gisondi P, Hamadah I, Kibbi AG, Shirazy K.
    J Dermatolog Treat; 2017 Mar 11; 28(2):129-135. PubMed ID: 27196814
    [Abstract] [Full Text] [Related]

  • 18. Costs of Common Psoriasis Medications, 2010-2014.
    James SM, Hill DE, Feldman SR.
    J Drugs Dermatol; 2016 Mar 11; 15(3):305-8. PubMed ID: 26954315
    [Abstract] [Full Text] [Related]

  • 19. New drugs and treatment targets in psoriasis.
    Kofoed K, Skov L, Zachariae C.
    Acta Derm Venereol; 2015 Feb 11; 95(2):133-9. PubMed ID: 25111317
    [Abstract] [Full Text] [Related]

  • 20. The role of biologics in the treatment of moderate-to-severe plaque psoriasis.
    Puig L.
    G Ital Dermatol Venereol; 2017 Feb 11; 152(1):28-35. PubMed ID: 27627100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.